Title: Doctors Struggle to Meet Demand for RSV Antibody Shot for Babies
Doctors across the country are facing difficulties in locating the RSV antibody shot to prevent Respiratory Syncytial… Read More
The CDC issued an alert to doctors about a shortage of certain doses of an RSV antibody drug Beyfortus given to newborns and infants to prevent RSV. Certain dosages are limited Read More
Cullen is a neonatologist and pediatrician.
Over the next few months, most of the U.S. will experience the annual explosion of respiratory infection… Read More
Respiratory syncytial virus (RSV) may no longer be the top cause of hospitalization among infants as two preventive treatments are now available. A maternal RSV vaccine given late in pregnan… Read More
Our wellness advice is expert-vetted. Our top picks are based on our editors’ independent research, analysis, and hands-on testing. If you buy through our links, we may get a commissio… Read More
Gorman is a public health and behavioral science expert. Scales is a professor of medicine. Cartwright is an ob/gyn.
Respiratory syncytial virus (RS… Read More
Our wellness advice is expert-vetted. Our top picks are based on our editors’ independent research, analysis, and hands-on testing. If you buy through our links, we may get a commissio… Read More
Last year’s “triple-demic” marked the beginning of what may be a new normal: a confluence of respiratory infections — RSV, influenza, and covid-19 — will surge… Read More
The CDC predicted that this year’s fall and winter virus season will look a lot like last year’s.
“The bottom line here is we’re likely to have a similar number of… Read More
In this video interview, Paul Offit, MD, of Children’s Hospital of Philadelphia, discusses the rationale behind the CDC recommendation for a yearly COVID booster, and how U.S. policy… Read More
Title: FDA Official Supports Spacing Out COVID, Flu, and RSV Vaccinations for Minimizing Side Effects
In a recent development, Dr. Peter Marks, the influential director of the FDA’s Ce… Read More
Moderna has announced that its experimental mRNA-based flu vaccine demonstrated a stronger immune response against four strains of the flu virus than an existing flu vaccine in a late-stage… Read More
A recent study published in JAMA Network Open highlights the impact of respiratory syncytial virus (RSV) on previously healthy babies. While RSV is known to pose a threat to preterm infants… Read More
The United States Food and Drug Administration (FDA) on Monday approved the first vaccination to save newborns from Respiratory Syncytial Virus
The US Food and Drug Administration (FDA) on… Read More
TAIZHOU, China, Aug. 27, 2023 /PRNewswire/ — Innovative vaccine company Recbio (02179.HK) announced its latest progress and interim results for 2023. During the reporting period, the… Read More
With 2023 bringing new tools to fight a common respiratory scourge, U.S. health officials on Thursday offered a preview of the Biden administration’s fall vaccine campaign, while ack… Read More
The Food and Drug Administration's recent approval of Beyfortus, a revolutionary drug developed by Sanofi and AstraZeneca, brings hope for protecting infants and toddlers against respiratory… Read More
Title: Experts Warn of Potential “Tripledemic” Strain on Hospitals as Flu and RSV Season Approaches
As the flu and respiratory syncytial virus (RSV) season approaches, experts ar… Read More
On today’s episode of the 5 Things podcast: Russia halts grain export deal after Crimea bridge explosion
Russia halts its grain export deal after a Crimean bridge explosion… Read More
Why It Matters: Older adults are at a higher risk.
Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from the virus, the F.D.A. estima… Read More